The project, dubbed FinnGen, was announced this week and is slated to run through mid-2023.
The Office of the National Coordinator for Health IT sees long-term potential in APIs for secure transfer of clinical and genomic data, but it's not quite there yet on the genomic side.
The head of the data center for the Precision Medicine Initiative's All of Us program discusses plans to manage records on 1 million people from dozens of sites.
The companies believe the database can facilitate outcomes research, improve variant interpretations, inform drug development efforts.
Brigham & Women's Ravi Parikh coauthored a recent NEJM commentary calling for a Precision Delivery Initiative to supplement the Precision Medicine Initiative.
An international team of researchers has mapped new associations between HLA mutations and specific diseases, and made their data freely accessible.
Founder Mark Harris and Gillian Hooker, VP of clinical development, explain why a more efficient Genetic Health Information Network is critical to the advancement of precision medicine.
The integration will allow Aprima EHR users to receive alerts about potentially harmful drug-genomic interactions when writing electronic prescriptions.
Investigators intend to genotype the biorepository using Illumina arrays with the aim of identifying markers that can be used to inform treatment and prevention efforts.
The system allows oncologists to pick treatment regimens using NantHealth's decision support tool, and order them directly through Allscript's EHR system.
A UK woman is suing three National Health Service Trusts for not telling her about her father's Huntington's disease diagnosis, the BBC reports.
LiveScience reports that a novel mutation in the LPL gene was uncovered in three siblings with very high triglyceride levels.
The president of Nankai University is embroiled in a data manipulation scandal, the South China Morning Post reports.
In PNAS this week: cytotoxic CD4 T cell signature in supercentenarians, evolutionary history of beetles, and more.